The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer
Open accessAbstract
Polymorphisms in the human genome contribute to wide variations in how individuals respond to medications, either by changing the pharmacokinetics of drugs or by altering the cellular response to therapeutic agents. The goal of the emerging discipline of pharmacogenomics is to personalize therapy based on an individual's genotype. Due to the relatively large frequency of single-nucleotide polymorphisms (SNP) in the human genome, synonymous SNPs are often disregarded in many pharmacogenomic studies based on the assumption that these are silent. We have shown recently that synonymous SNPs in ABCB1 (P-glycoprotein), which is implicated both in determining drug pharmacokinetics and multidrug resistance in human cancer cells, can affect protein conformation and function. We discuss the importance of polymorphisms in drug metabolizing enzymes and transporters in anticancer therapy and suggest that synonymous polymorphisms may play a more significant role than is currently assumed. [Cancer Res 2007;67(20):9609–12]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848
Laws, S. M., Hone, E., Gandy, S., & Martins, R. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01615.x · Cited by 223
How do synonymous mutations affect fitness?
Parmley, J. L., & Hurst, L. D. (2007) · BioEssays · doi:10.1002/bies.20592 · Cited by 142
Cited by
Understanding the contribution of synonymous mutations to human disease
Sauna, Z. E., & Kimchi-Sarfaty, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3051 · Cited by 1,022
Self-citationA synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Fung, K. L., & Gottesman, M. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.014 · Cited by 335
Self-citationAngov, E., Hillier, C. J., Kincaid, R. L., & Lyon, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002189 · Cited by 283
Development of Exercise as Interception Therapy for Cancer: A Review
Iyengar, N. M., & Jones, L. W. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2585 · Cited by 67
Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis
Li, N., Dong, J., Hu, Z., Shen, H., & Dai, M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0532-9 · Cited by 56
Metadata
- Authors
- Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., & Gottesman, M. M.
- Venue
- Cancer Research
- Published
- 2007-10-15
- Volume
- 67
- Issue
- 20
- Pages
- 9609-9612
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1985346980
- Cited by
- 243
- References
- 4
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2377
- The paper
- Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., & Gottesman, M. M. (2007). Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2377
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.